Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.11 USD | -10.00% |
|
+8.22% | -19.75% |
Evolution of the average Target Price on Prime Medicine, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Prime Medicine, Inc.
HC Wainwright | |
Citigroup | |
JPMorgan Chase | |
Chardan Research | |
Wedbush | |
Guggenheim | |
Morgan Stanley | |
BMO Capital | |
JonesTrading Institutional Services | |
Stifel Nicolaus | |
Jefferies & Co. | |
Goldman Sachs |
EPS Revisions
- Stock Market
- Equities
- PRME Stock
- Consensus Prime Medicine, Inc.